Whoop's Longitudinal Health Data Platform
Whoop
The real opportunity is that Whoop can sell not just a wearable membership, but a longitudinal health data layer that researchers, providers, and employers can plug into. The strap already captures heart rate variability, respiratory rate, sleep, and recovery continuously, and Whoop is now linking that stream with blood biomarkers through Advanced Labs and with de identified healthcare data through Datavant, which makes the product more useful for trials, remote monitoring, and outcomes research.
-
Clinical expansion is becoming operational, not theoretical. Whoop partnered with Datavant to connect wearable signals to real world healthcare datasets for clinicians, researchers, payers, and life sciences groups, and in February 2026 joined a Stanford led, ARPA-H backed coalition building an FDA grade aging score.
-
Whoop is also building the workflow layer needed for healthcare use cases. Advanced Labs combines 65 biomarker blood panels with continuous wearable data inside the app, and new diagnostic partnerships like Unilabs extend that model beyond the core consumer subscription into test based, health oriented revenue.
-
The closest comparable is Oura, which is also pushing into providers, remote patient monitoring, and enterprise health. The difference is that Oura leans on ring based comfort, retail scale, and Dexcom integration, while Whoop leans on always on training and recovery data, team deployments, and a subscription that already conditions users to continuous monitoring.
The next phase is a shift from consumer fitness tool to research and care infrastructure. If Whoop keeps layering lab testing, health system integrations, and publishable research on top of its daily biometric stream, it can move into higher value contracts where the customer is a clinic, employer, sports organization, or trial sponsor rather than just an individual member.